Alexion deal lends late-stage support to Stealth

Alexion continued its run of deals by obtaining an option to a Phase III candidate from Stealth, which would get a boost in building its commercial infrastructure ahead of a regulatory submission next year and be able to devote more resources to its earlier stage programs.

Alexion Pharmaceuticals Inc.

Read the full 495 word article

How to gain access

Continue reading with a
two-week free trial.